24/7 Market News- Keep an Eye on Quoin Pharmaceuticals (NASDAQ: QNRX)

August 17, 2022 7:57 a.m. EDT

(24/7 MARKET NEWS) — Quoin Pharmaceuticals (NASDAQ: QNRX) is perking up in this morning’s premarket, trading at $6.07, up $1.06 (+21.15%), on 2.68 million shares.

The specialty pharmaceutical company is scheduled to report its second quarter 2022 financial results before the financial markets open tomorrow morning and, considering how Quoin Pharmaceuticals started the month out with a nearly 500% intraday gain on the 3rd, it’s certainly worth keeping on your screen.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist